Mineral Supplements Market Size, Share & Trends Analysis Report By Product (Calcium, Magnesium), By End-use, By Formulation, By Application, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030

Mineral Supplements Market Size, Share & Trends Analysis Report By Product (Calcium, Magnesium), By End-use, By Formulation, By Application, By Sales Channel, By Region, And Segment Forecasts, 2024 - 2030


Mineral Supplements Market Growth & Trends

The global mineral supplements market size is anticipated to reach USD 23.99 billion by 2030 and is projected to grow at a CAGR of 5.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factor influencing the industry growth is the growing worldwide incidence of chronic diseases such as anemia, osteoporosis, cancer, and diabetes is boosting the growth as these supplements are useful for managing such conditions. The rising adoption of a sedentary lifestyle has led to the rising cases of lifestyle disorders.

The growing incidence of bone-related sports injuries reflects the intensifying athletic culture and growing participation in physical activities across all age groups. The rise in injuries such as fractures, stress fractures, and bone bruises, can be attributed to various factors, including high-impact & competitive sports and intense training regimens, which put considerable stress on the skeletal system. Activities such as running, basketball, soccer, and weightlifting involve repetitive motions or sudden impacts that can strain or injure bones. Moreover, inadequate warmup routines, improper technique, or overtraining without sufficient rest periods can increase vulnerability to bone injuries. These supplements, rich in calcium, vitamin D, and other minerals, serve as a complementary measure to support bone health, aiding in injury prevention and faster recovery among athletes and it expected to drive the market in forecast years.

The working age groups are more susceptible to mineral deficiencies due to several lifestyle factors. Sedentary desk jobs, hectic schedules, and reliance on processed foods have contributed to inadequate intake & absorption of essential minerals. This trend has led to a rise in mineral deficiencies among the working demographic, impacting their overall health and productivity. Environmental factors, such as pollution and limited exposure to sunlight can hinder the absorption of certain minerals like vitamin D and calcium, affecting bone health and overall well-being. Consequently, individuals in the workforce are turning to mineral supplements to bridge the nutritional gap and combat these deficiencies. Supplements offer a convenient and effective way to ensure adequate intake of essential minerals, aiding in maintaining optimal.

Furthermore, low awareness levels in emerging economies can significantly restrain the mineral supplements market. Limited understanding of the benefits, cultural differences, and varying healthcare perceptions hinder product penetration. In these regions, inadequate education about nutritional deficiencies and the role of supplements creates a barrier to consumer adoption. Addressing these awareness gaps through targeted educational campaigns and culturally sensitive marketing strategies is pivotal to unlocking the market's potential and fostering acceptance of mineral supplements in emerging economies.

Mineral Supplements Market Report Highlights
  • Based on the product, the calcium segment led the market with the largest revenue share of 41.9% in 2023, due to increasing consumption by adults and geriatric population due to calcium deficiency
  • Based on the formulation, the tablet segment held the largest revenue share in 2023, formulation segment due to the availability of majority of products in the form of tablets
  • Based on the application, the general health segment dominated the market with the largest revenue share in 2023 and it is expected to grow at fastest CAGR over the forecast period
  • Based on the end-use, the adults segment dominated the market with a largest revenue share in 2023, due to the increasing mineral deficiencies and the high prevalence of calcium deficiency in working women
  • Based on the sales channel, the pharmacies & drug stores segment dominated the market in 2023, and online the channels segment is expected to grow at fastest CAGR over the forecast period
  • Asia Pacific dominated the market owing to factors such as a large target population, increasing awareness regarding supplementation, and an increasing geriatric population
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Formulation
1.2.3. Application
1.2.4. End-use
1.2.5. Sales Channel
1.3. Estimates and forecasts timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased database
1.5.2. GVR’s internal database
1.5.3. Secondary sources
1.5.4. Primary research
1.5.5. Details of primary research
1.6. Information or Data Analysis
1.6.1. Data analysis models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity flow analysis (Model 1)
1.8.2. Approach 1: Commodity flow approach
1.8.3. Volume price analysis (Model 2)
1.8.4. Approach 2: Volume price analysis
1.9. List of Secondary Sources
1.10. List of Primary Sources
1.11. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Mineral Supplements Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing Geriatric Population
3.2.1.2. Rising Mineral Deficiencies in Working Population
3.2.1.3. Increasing Bone Related Sports Injuries
3.2.2. Market restraint analysis
3.2.2.1. Low awareness levels in emerging economies
3.3. Industry Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Mineral Supplements Market: Product Estimates & Trend Analysis
4.1. Global Mineral Supplements Market by Product Outlook
4.2. Calcium
4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3. Magnesium
4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4. Iron
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Potassium
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Zinc
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Chromium
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Selenium
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Others
4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Mineral Supplements Market: Formulation Estimates & Trend Analysis
5.1. Global Mineral Supplements Market by Formulation Outlook
5.2. Capsule
5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3. Tablet
5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4. Powder
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Liquid/Gel
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Mineral Supplements Market: Application Estimates & Trend Analysis
6.1. Global Mineral Supplements Market by Application Outlook
6.2. General Health
6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3. Bone & Joint health
6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4. Gastrointestinal Health
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Immunity
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Mineral Supplements Market: End-use Estimates & Trend Analysis
7.1. Global Mineral Supplements Market by End-use Outlook
7.2. Adults
7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3. Geriatric
7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Pregnant Women
7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Children
7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Infants
7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Mineral Supplements Market: Sales Channel Estimates & Trend Analysis
8.1. Global Mineral Supplements Market by Sales Channel Outlook
8.2. Pharmacies & Drug Stores
8.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.3. Supermarkets & Hypermarkets
8.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.4. Online Channels
8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Mineral Supplements Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. North America
9.2.1. U.S.
9.2.1.1. Key country dynamics
9.2.1.2. Regulatory framework
9.2.1.3. Competitive scenario
9.2.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.2.1.5. Target disease prevalence
9.2.2. Canada
9.2.2.1. Key country dynamics
9.2.2.2. Regulatory framework
9.2.2.3. Competitive scenario
9.2.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.2.2.5. Target disease prevalence
9.3. Europe
9.3.1. UK
9.3.1.1. Key country dynamics
9.3.1.2. Regulatory framework
9.3.1.3. Competitive scenario
9.3.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.3.1.5. Target disease prevalence
9.3.2. Germany
9.3.2.1. Key country dynamics
9.3.2.2. Regulatory framework
9.3.2.3. Competitive scenario
9.3.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.3.2.5. Target disease prevalence
9.3.3. France
9.3.3.1. Key country dynamics
9.3.3.2. Regulatory framework
9.3.3.3. Competitive scenario
9.3.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.3.3.5. Target disease prevalence
9.3.4. Italy
9.3.4.1. Key country dynamics
9.3.4.2. Regulatory framework
9.3.4.3. Competitive scenario
9.3.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.3.4.5. Target disease prevalence
9.3.5. Spain
9.3.5.1. Key country dynamics
9.3.5.2. Regulatory framework
9.3.5.3. Competitive scenario
9.3.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.3.5.5. Target disease prevalence
9.3.6. Norway
9.3.6.1. Key country dynamics
9.3.6.2. Regulatory framework
9.3.6.3. Competitive scenario
9.3.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.3.6.5. Target disease prevalence
9.3.7. Sweden
9.3.7.1. Key country dynamics
9.3.7.2. Regulatory framework
9.3.7.3. Competitive scenario
9.3.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.3.7.5. Target disease prevalence
9.3.8. Denmark
9.3.8.1. Key country dynamics
9.3.8.2. Regulatory framework
9.3.8.3. Competitive scenario
9.3.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.3.8.5. Target disease prevalence
9.4. Asia Pacific
9.4.1. Japan
9.4.1.1. Key country dynamics
9.4.1.2. Regulatory framework
9.4.1.3. Competitive scenario
9.4.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.4.1.5. Target disease prevalence
9.4.2. China
9.4.2.1. Key country dynamics
9.4.2.2. Regulatory framework
9.4.2.3. Competitive scenario
9.4.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.4.2.5. Target disease prevalence
9.4.3. India
9.4.3.1. Key country dynamics
9.4.3.2. Regulatory framework
9.4.3.3. Competitive scenario
9.4.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.4.3.5. Target disease prevalence
9.4.4. Australia
9.4.4.1. Key country dynamics
9.4.4.2. Regulatory framework
9.4.4.3. Competitive scenario
9.4.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.4.4.5. Target disease prevalence
9.4.5. South Korea
9.4.5.1. Key country dynamics
9.4.5.2. Regulatory framework
9.4.5.3. Competitive scenario
9.4.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.4.5.5. Target disease prevalence
9.4.6. Thailand
9.4.6.1. Key country dynamics
9.4.6.2. Regulatory framework
9.4.6.3. Competitive scenario
9.4.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.4.6.5. Target disease prevalence
9.5. Latin America
9.5.1. Brazil
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework
9.5.1.3. Competitive scenario
9.5.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.5.1.5. Target disease prevalence
9.5.2. Mexico
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework
9.5.2.3. Competitive scenario
9.5.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2.5. Target disease prevalence
9.5.3. Argentina
9.5.3.1. Key country dynamics
9.5.3.2. Regulatory framework
9.5.3.3. Competitive scenario
9.5.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.5.3.5. Target disease prevalence
9.6. MEA
9.6.1. South Africa
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework
9.6.1.3. Competitive scenario
9.6.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.6.1.5. Target disease prevalence
9.6.2. Saudi Arabia
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework
9.6.2.3. Competitive scenario
9.6.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2.5. Target disease prevalence
9.6.3. UAE
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework
9.6.3.3. Competitive scenario
9.6.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3.5. Target disease prevalence
9.6.4. Kuwait
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework
9.6.4.3. Competitive scenario
9.6.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4.5. Target disease prevalence
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2023
10.4. Company Profiles/Listing
10.4.1. Glanbia PLC
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Abbott
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Nestle
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. BIOVEA
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. Herbalife International of America, Inc.
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. Sanofi (Qunol)
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Schwabe Group (Nature's Way)
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. OstroVit
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Pharmavite
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. New Chapter, Inc.
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings